RethinkBronchiectasis.com by Insmed Incorporated is a source of information and resources on bronchiectasis for healthcare professionals.
Bronchiectasis is a chronic and progressive disease usually marked by permanent, abnormal dilation and persistent inflammation of the airways. There have long been unmet needs in bronchiectasis, though it affects approximately 450,000 people in the United States and more globally.
Bronchiectasis is commonly associated with symptoms of chronic cough, daily sputum production, and recurrent infections. It initially presents with nonspecific symptoms that mimic more common conditions such as COPD or asthma, which experts believe often delays diagnosis or leads to misdiagnoses. Bronchiectasis also notably causes exacerbations in which patients experience the worsening of multiple symptoms, requiring a change in treatment.
To disrupt the vicious vortex of disease progression, a comprehensive management approach is required, focusing on all 4 primary drivers of the disease: addressing chronic airway infection, reducing chronic airway inflammation—primarily neutrophilic, enhancing mucociliary clearance, and preventing further lung destruction.
For more information about managing and treating bronchiectasis, visit RethinkBronchiectasis.com.
© 2023 Insmed Incorporated. All Rights Reserved. Insmed is a trademark of Insmed Incorporated. All other trademarks are property of their respective owner. NP-BE-US-00156
Company Details
- Address
- Bridgewater, New Jersey, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- New York.
- HQ
- Bridgewater, New Jersey
- Competitors
- Bronchiectasis News Today, EMBARC - The European Bronchiectasis Network, World Bronchiectasis & NTM Conference, European Lung Foundation, Respiratory Therapy Zone, Insmed Incorporated, HELEN AND DR ARTHUR PRESS FOUNDATION FOR BRONCHIECTASIS, BE CLEAR with Bronchiectasis, LLC - A BE & NTM patient advocacy consulting company, Bronchiectasis Foundation, H2CYL Asociación Castellano y Leonesa del Hidrógeno.
Rethink Bronchiectasis Questions
Rethink Bronchiectasis's website is https://rethinkbronchiectasis.com/
Rethink Bronchiectasis's LinkedIn profile is https://www.linkedin.com/company/rethink-bronchiectasis
Rethink Bronchiectasis's industry is
Biotechnology Research
Rethink Bronchiectasis's top competitors are
Bronchiectasis News Today,
Embarc - The European Bronchiectasis Network,
World Bronchiectasis & Ntm Conference,
European Lung Foundation,
Respiratory Therapy Zone,
Insmed Incorporated,
Helen And Dr Arthur Press Foundation For Bronchiectasis,
Be Clear With Bronchiectasis, Llc - A Be & Ntm Patient Advocacy Consulting Company,
Bronchiectasis Foundation,
H2cyl Asociación Castellano Y Leonesa Del Hidrógeno.
Rethink Bronchiectasis's categories are Biotechnology Research
